Evidence map›Paper›PMID 28218709›Full record

ReviewInternational journal of molecular sciences2017

PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.

Clément Bailly, Rodolphe Leforestier, Bastien Jamet, Thomas Carlier, Mickael Bourgeois, François Guérard, Cyrille Touzeau, Philippe Moreau, Michel Chérel, Françoise Kraeber-Bodéré and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow.Journal of cancer research and clinical oncology · 2019
    Article
  7. Article
  8. European journal of nuclear medicine and molecular imaging · 2019
    Article
  9. Clinical relevance of PET/CT in patients with newly diagnosed multiple myeloma.International journal of clinical and experimental pathology · 2019
    Article
  10. Tonsillar plasmacytoma in a dog.The Canadian veterinary journal = La revue veterinaire canadienne · 2018
    Article
  11. Article
  12. The Role ofContrast media & molecular imaging · 2018
    Article
  13. Spectrum of Flurodeoxyglucose Positron Emission Tomography/Computerized Tomography Findings in Tumors and Tumor-Like Conditions of the Musculoskeletal System.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
  14. Light-Chain Myeloma Presented as Osseus Tumors: A Case Report.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Clément BaillyNantes-Angers Cancer Research Center (CRCNA), University of Nantes, Inserm UMR 1232, 8 quai Moncousu, 44007 Nantes, France. clement.bailly@chu-nantes.fr.
Rodolphe LeforestierDepartment of Nuclear Medicine, CHU de Nantes, 1 place Alexis Ricordeau, 44093 Nantes, France. rodolpheleforestier@hotmail.fr.
Bastien JametDepartment of Nuclear Medicine, CHU de Nantes, 1 place Alexis Ricordeau, 44093 Nantes, France. bastien.jamet@chu-nantes.fr.
Thomas CarlierNantes-Angers Cancer Research Center (CRCNA), University of Nantes, Inserm UMR 1232, 8 quai Moncousu, 44007 Nantes, France. thomas.carlier@chu-nantes.fr.
Mickael BourgeoisNantes-Angers Cancer Research Center (CRCNA), University of Nantes, Inserm UMR 1232, 8 quai Moncousu, 44007 Nantes, France. mickael.bourgeois@nantes.inserm.fr.
François GuérardNantes-Angers Cancer Research Center (CRCNA), University of Nantes, Inserm UMR 1232, 8 quai Moncousu, 44007 Nantes, France. francois.guerard@univ-nantes.fr.
Cyrille TouzeauDepartment of Nuclear Medicine, CHU de Nantes, 1 place Alexis Ricordeau, 44093 Nantes, France. cyrille.touzeau@chu-nantes.fr.
Philippe MoreauDepartment of Nuclear Medicine, CHU de Nantes, 1 place Alexis Ricordeau, 44093 Nantes, France. philippe.moreau@chu-nantes.fr.
Michel ChérelNantes-Angers Cancer Research Center (CRCNA), University of Nantes, Inserm UMR 1232, 8 quai Moncousu, 44007 Nantes, France. michel.cherel@univ-nantes.fr.
Françoise Kraeber-BodéréNantes-Angers Cancer Research Center (CRCNA), University of Nantes, Inserm UMR 1232, 8 quai Moncousu, 44007 Nantes, France. francoise.bodere@chu-nantes.fr.
Caroline Bodet-MilinNantes-Angers Cancer Research Center (CRCNA), University of Nantes, Inserm UMR 1232, 8 quai Moncousu, 44007 Nantes, France. caroline.milin@chu-nantes.fr.
Centre Hospitalier Universitaire de Nantes · FRInserm · FRNantes Université · FRCentre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple myeloma (MM) is a hematological neoplasm characterized by the clonal proliferation of malignant plasma cells in the bone marrow. MM results in diffuse or focal bone infiltration and extramedullary lesions. Over the past two decades, advances have been made with regard to the diagnosis, staging, treatment, and imaging of MM. Computed tomography (CT) and magnetic resonance imaging (MRI) are currently recommended as the most effective imaging modalities at diagnostic. Yet, recent data from the literature suggest that positron emission tomography combined with computed tomography (PET/CT) using

Indexed as

Positron-Emission TomographyBone DiseasesDiagnosis, DifferentialFluorodeoxyglucose F18HumansMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaNeoplasm StagingPositron Emission Tomography Computed TomographyPrognosisRadiopharmaceuticalsRecurrenceTreatment OutcomeFluorodeoxyglucose F18Radiopharmaceuticalsmultiple myelomaPET/CTsolitary plasmacytomatherapeutic evaluation

Identifiers

PMID28218709
PMCPMC5343979
OpenAlexW2591274967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.